Skip to content

ULTRASCORE US3513068Recalls & reported problems

Bard Peripheral Vascular, Inc. · ULTRASCORE™ Focused Force PTA Balloon 6mm x 80mm, 130cm catheter · Class 2

All models of ULTRASCORE (61)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00801741116865), received between Aug 7, 2018 and Feb 20, 2024 — classified as 3 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Detachment of Device or Device Component1
  • Difficult to Remove1
  • Failure to Advance1
  • Leak/Splash1
  • Material Split, Cut or Torn1

Patient problems

  • Vascular Dissection3
  • No Clinical Signs, Symptoms or Conditions2
  • Occlusion1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 20, 2024Difficult to Remove; Failure to Advance; Detachment of Device or Device Component; Difficult to Remove; Failure to Advance; Detachment of Device or Device Component

    IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE IN THE SEVERELY CALCIFIED STENOSIS OF A POPLITEAL ARTERY VIA THE LEFT GROIN, THE PTA BALLOON ALLEGEDLY FAILED TO CROSS THE LESION. IT WAS FURTHER REPORTED THAT THE PTA BALLOON WAS ALLEGEDLY DIFFICULT TO BE REMOVED AND HAD VERY HARD RESISTANCE. IT WAS FURTHER REPORTED THAT THE WIRES ALLEGEDLY DETACHED FROM THE BALLOON. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18738972 ↗
  • MalfunctionJan 23, 2024Leak/Splash; Material Split, Cut or Torn; Leak/Splash; Material Split, Cut or Torn

    IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE IN THE LEFT LEG VIA RIGHT FEMORALIS COMMUNIS, THE FLUID ALLEGEDLY DROPPED OUT BETWEEN THE CONNECTION HUB AND THE CATHETER WHEN PRESSURE WAS APPLIED TO THE BALLOON. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18562424 ↗
  • InjuryJan 23, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT FOLLOWING AN ANGIOPLASTY PROCEDURE IN THE PROXIMAL 1/3 AND MID 1/3 OF THE RIGHT SUPERFICIAL FEMORAL ARTERY WITH A FOCUSED FORCE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON DILATATION CATHETER, DISSECTION WAS IDENTIFIED WHICH REQUIRED PLACEMENT OF A STENT. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Vascular Dissection

    MAUDE report 8272515 ↗
  • InjuryNov 29, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT DURING AN ANGIOPLASTY PROCEDURE WITH A FOCUSED FORCE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON DILATATION CATHETER, VESSEL DISSECTION WAS IDENTIFIED AFTER THREE INFLATIONS IN THE LEFT SUPERFICIAL FEMORAL ARTERY. REPORTEDLY, THE DISSECTION WAS TREATED WITH A DRUG ELUTING STENT. THE EVENT WAS CONSIDERED TO BE RESOLVED. THE SUBJECT WAS DISCHARGED ONE DAY AFTER THE INDEX PROCEDURE.

    Patient problems: Occlusion; Vascular Dissection

    MAUDE report 8118464 ↗
  • InjuryAug 7, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL, THAT DURING AN ANGIOPLASTY PROCEDURE WITH A FOCUSED FORCE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON DILATATION CATHETER, VESSEL DISSECTION WAS IDENTIFIED AFTER INFLATION IN THE SUPERFICIAL FEMORAL ARTERY. REPORTEDLY, THE DISSECTION WAS TREATED WITH A NON DRUG COATED PTA BALLOON DILATATION CATHETER AND THE EVENT WAS CONSIDERED TO BE RESOLVED.

    Patient problems: Vascular Dissection

    MAUDE report 7760420 ↗

Other Catheter, percutaneous, cutting/scoring devices

All Catheter, percutaneous, cutting/scoring devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page